Key result
The incidence of postoperative residual neuromuscular blockade in the post-anesthesia care unit was 19% among adults receiving non-depolarizing neuromuscular blockers.
Why the study?
The incidence of postoperative residual neuromuscular blockade varies significantly across studies and associated risk factors have not been consistent.
Cohort (n=300)
No
Postoperative residual neuromuscular blockade remains common (19% incidence) despite current guidelines, with female gender, abdominal surgery, multiple ND-NMB doses, and lack of pharmacological reversal identified as key risk factors.
RNMB was associated with postoperative complications in this cohort; leaves open whether monitoring or reversal protocols improve outcomes.
Introduction: The use of non-depolarizing neuromuscular blockers (ND-NMB) is essential in anesthetic management as it improves ventilation conditions, airway management, and surgical conditions. However, the residual neuromuscular blockade (RNMB) in the immediate postoperative period derived from the use of these agents is associated with complications such as desaturation, pneumonia, and unplanned intensive care unit admission. The incidence varies significantly across different studies, and associated risk factors have not been consistent. Objectives: To estimate the incidence of RNMB and to identify characteristics of intraoperative management and potential risk factors for RNMB. Methods: A prospective observational study was conducted at a university hospital, using convenience sampling. Train-of-four (TOF) measurements were performed in the post-anesthesia care unit. An exploratory multivariate analysis was performed to identify potential risk factors. Results: A total of 300 patients were included. The incidence of residual neuromuscular blockade (RNMB) was 19% (95% CI: 14.9% - 23.8%). Evidence of relaxation monitoring was observed in 21.3% of the patients. Significant associations with RNMB were found for female gender (OR 1.97, 95% CI 1.02 – 3.81), absence of pharmacological reversal (OR 2.31, 95% CI 1.02 – 5.24), abdominal surgery (OR 2.81, 95% CI 1.37 – 5.72), and multiple intraoperative doses of ND-NMBs (OR 2.77, 95% CI 1.48 – 5.18). Conclusions: Residual neuromuscular blockade (RNMB) is common in our setting, with a low frequency of intraoperative monitoring. The associated risk factors identified can point to specific scenarios that require special attention.
No takes yet. Share an insight, caveat, or question.
Vélez-Agudelo et al. (2025) conducted a cohort in Postoperative residual neuromuscular blockade (RNMB) (n=300). Non-depolarizing neuromuscular blockers (ND-NMB) was evaluated on Incidence of residual neuromuscular blockade (RNMB) in the PACU (TOFr < 0.9) (95% CI 14.9% - 23.8%). The incidence of postoperative residual neuromuscular blockade in the post-anesthesia care unit was 19% among adults receiving non-depolarizing neuromuscular blockers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: